NovaBay Pharmaceuticals, Inc. Provides Business Unit Update And 2014 Outlook
Published: Jan 08, 2014
EMERYVILLE, Calif., Jan. 8 2014 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, today provided a business update highlighting recent accomplishments and outlook for 2014.
Help employers find you! Check out all the jobs and post your resume.